新一代排卵針corifollitropin alfa
於月經第2天施打一劑即可
研究顯示其重複使用並不會造成免疫性抗體 間接證實其安全性
Outcome | IVIG group (n = 23) | Control group (n = 24) | OR (95% CI)* | P-value |
---|---|---|---|---|
Live birth rate | 16/23 (70%) | 15/24 (63%) | 1.37 (0.41–4.61) | 0.760 |
Live birth rate, excluding biochemical miscarriages | 16/20 (80%) | 15/20 (75%) | 1.33 (0.30–5.93) | >0.999 |
Live birth rate, excluding miscarriages <6 weeks of gestation | 16/17 (94%) | 15/16 (94%) | 1.07 (0.06–18.62) | >0.999 |
Variables | DHEA (n= 26) | Control (n = 25) | P-value |
---|---|---|---|
Mean E2a on hCG (pg/ml) | 732 ± 337 | 917 ± 487 | 0.2 |
Mean E2 per retrieved oocyte (pg/ml) | 239 ± 120 | 335 ± 150 | 0.35 |
Mean progesterone on hCG (ng/ml) | 0.8 ± 0.6 | 0.7 ± 0.4 | 0.71 |
Endometrial thickness on hCG (mm) | 10.5 ± 2.5 | 10.8 ± 2.8 | 0.74 |
Mean number of retrieved oocytes | 3.2 ± 1.6 | 3.5 ± 2.4 | 0.65 |
Fertilization rate (%) | 58.20% | 56.30% | 0.42 |
Mean no. of embryo transfer | 2.1 ± 1.0 | 2.2 ± 0.7 | 0.73 |
Mean scoring of leading embryo transfer | 3.1 ± 0.5 | 3.3 ± 0.4 | 0.42 |
Clinical Pregnancy (%) | 7 (26.9%) | 3 (12.0%) | 0.07 |
Live birth rate | 6 (23.1%) | 1 (4.0%) | 0.05 |